Inaccurate cancer tests leave two dead

Jan 18, 2008

Inaccurate cancer tests may have contributed to the deaths of two people and thousands must be retested after a North Wales doctor misread test results.

Approximately 4,500 people need retesting after a clinical examination of cancer tests given by Dr. Roger Williams discovered 12 questionable results -- two which belonged to two dead patients, The Daily Telegraph reported Thursday.

Three people who Williams, 64, told were cancer-free have begun treatment for the disease. He reportedly resigned from his job as a part-time clinician after the errors were found.

People tested by Williams as far back as 2004 are set for re-examination.

"The errors initially identified three patients who had been advised that their tissue samples did not give reason for concern when in fact they should have been told that they were clinically suspicious and, in some cases, actually indicative of cancer," a statement from the North East Wales NHS Trust said.

The results of the 4,500 test re-examinations will give doctors a fix on whether it is a marginal or significant problem, said Chief Executive of the Trust, Marry Burrows.

Copyright 2008 by United Press International

Explore further: 'Stem cell' test could identify most aggressive breast cancers

add to favorites email to friend print save as pdf

Related Stories

Braving the cold to understand what makes squirrels tick

Jan 06, 2015

For most of us, our day begins with an alarm of some sort. We work, eat, and play, all on some sort of a schedule. While our world is dictated by mechanical clocks, the schedule of the non-human animal kingdom ...

Bitter food but good medicine from cucumber genetics

Nov 27, 2014

High-tech genomics and traditional Chinese medicine come together as researchers identify the genes responsible for the intense bitter taste of wild cucumbers. Taming this bitterness made cucumber, pumpkin ...

Recommended for you

Opdivo approval expanded to include lung cancer

4 hours ago

(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

First-of-its kind reference on pelvic malignancies

5 hours ago

Loyola University Medical Center radiation oncologist William Small, Jr., MD, FACRO, FACR, FASTRO, is co-editor of Pelvic Malignancy and its Consequences, the first-of-its kind stand-alone reference on the subject.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.